AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Sectors:
Industries:
Analyst Ranking
Top 2%
#47 out of 3732 analysts
Average Return
+52.94%
Win Rate
47%21 out of 45
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
NOVAVAX INCNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-26 - 2021-03-26 | Strong Buy |
NOVAVAX INCNVAX | +946.95% | $19.83 | $207.61 | 2020-04-23 - 2021-04-23 | Strong Buy |
FORTRESS BIOTECH INCFBIO | +221.05% | $1.33 | $4.27 | 2020-03-12 - 2021-03-12 | Strong Buy |
ARROWHEAD PHARMACEUTICALS INCARWR | +176.37% | $26.32 | $72.74 | 2020-03-12 - 2021-03-12 | Strong Buy |
NOVAVAX INCNVAX | +149.90% | $83.61 | $208.94 | 2020-06-28 - 2021-06-29 | Strong Buy |
Mayank Mamtani's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
VAXART INCVXRT | 2 | Hold | $6.00 | +61.29% | Maintains | 4 days ago |
X4 PHARMACEUTICALS INCXFOR | 2 | Strong Buy | $7.00 | +503.45% | Maintains | 4 days ago |
CYMABAY THERAPEUTICS INCCBAY | 2 | Strong Buy | $8.00 | +280.95% | Maintains | 5 days ago |
NOVAVAX INCNVAX | 7 | Strong Buy | $203.00 | +280.01% | Maintains | a month ago |
TG THERAPEUTICS INCTGTX | 3 | Strong Buy | $23.00 | +326.72% | Maintains | a month ago |
TFF PHARMACEUTICALS INCTFFP | 1 | Strong Buy | $18.00 | +227.87% | Maintains | 2 months ago |
GAIN THERAPEUTICS INCGANX | 2 | Strong Buy | $16.00 | +479.71% | Maintains | 2 months ago |
FREQUENCY THERAPEUTICS INCFREQ | 1 | Strong Buy | $10.00 | +800.90% | Maintains | 2 months ago |
ALLENA PHARMACEUTICALS INCALNA | 3 | Hold | $0.50 | +323.73% | Downgrades | 2 months ago |
SPECTRUM PHARMACEUTICALS INCSPPI | 3 | Strong Buy | $4.00 | +438.36% | Maintains | 2 months ago |
NIGHTHAWK BIOSCIENCES INCNHWK | 1 | Strong Buy | $8.00 | +247.83% | Maintains | 2 months ago |
SEELOS THERAPEUTICS INCSEEL | 2 | Strong Buy | $4.00 | +534.92% | Maintains | 2 months ago |
INMUNE BIO INCINMB | 1 | Strong Buy | $20.00 | +172.11% | Maintains | 4 months ago |
MUSTANG BIO INCMBIO | 1 | Strong Buy | $6.00 | +748.66% | Maintains | 4 months ago |
CASSAVA SCIENCES INCSAVA | 2 | Strong Buy | $72.00 | +186.28% | Maintains | 4 months ago |
INTERCEPT PHARMACEUTICALS INCICPT | 3 | Strong Buy | $30.00 | +71.82% | Upgrades | 4 months ago |
BIOVIE INCBIVI | 1 | Strong Buy | $27.00 | +844.06% | Maintains | 6 months ago |
ALTIMMUNE INCALT | 1 | Strong Buy | $21.00 | +318.33% | Maintains | a year ago |
ELOXX PHARMACEUTICALS INCELOX | 1 | Strong Buy | $5.00 | +1,388.10% | Initiates Coverage On | a year ago |
ARROWHEAD PHARMACEUTICALS INCARWR | 2 | Strong Buy | $106.00 | N/A | Maintains | a year ago |
ARCTURUS THERAPEUTICS HOLDINGS INCARCT | 2 | Hold | $77.00 | N/A | Downgrades | a year ago |
ACASTI PHARMA INCACST | 1 | Strong Buy | $2.00 | N/A | Upgrades | 2 years ago |
GALMED PHARMACEUTICALS LTDGLMD | 2 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
GALECTIN THERAPEUTICS INCGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
IMV INCIMV | 1 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
LIBERTY MEDIA CORPFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 2 years ago |
MEDICINOVA INCMNOV | 1 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
GENFIT SAGNFT | 1 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
FORTRESS BIOTECH INCFBIO | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
NGM BIOPHARMACEUTICALS INCNGM | 1 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
ARQULE INCARQL | 1 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.